Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,179

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Neuropsychiatric Disease and Treatment

Open access
·2020·Neuropsychiatric Disease and Treatment

Abstract

Official journal of the International Neuropsychiatric Association (INA) Indexed: - The American Psychological Association's PsycINFO database- EmBase, Scopus and the Elsevier Bibliographic databases- American Chemical Society's Chemical Abstracts Service (CAS)- PubMed (files to appear soon)ISSN 1176-6328 (Print)ISSN 1178-2021 (Online)An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.Key benefitsConcise rapid reporting Clinical therapeutics and pharmacology focus Neuropsychiatric and neurological disorders Aims and scopeSubject areas include:Clinical studies throughout the drug development processSafety, outcome, and economic studiesPsychiatric illness including depression, schizophrenia, and anxiety disordersNeurological disorders including Parkinson's disease, epilepsy, pain, Alzheimer's disease, and othersContributions in basic and preclinical science are welcome where they elucidate disease processes in humans or novel treatment modalities.These areas are addressed through:Original clinical research (full papers and concise rapid reports)ReviewsBasic science studies that shed light on disease pathogenesis or the mode of action of treatmentsSystematic reviews of individual new or important drugs. Such reviews will normally be commissionedExpert opinion and commentary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 1,179

Metadata

Venue
Neuropsychiatric Disease and Treatment
Published
2020-03-12
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W4246108751
Cited by
1,179
References
1
Type
paratext
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.